Pfizer drops AstraZeneca takeover bid: American drugs giant admits defeat and scraps offer for British pharmaceutical company

US pharmaceutical giant had until 5pm to pursue bid or walk away

Deputy Business Editor

Pfizer, the US Viagra giant, has scrapped its takeover offer for Britain’s AstraZeneca, bringing an end to one of the most politically charged corporate deals in decades.

The company had until 5pm today to make up its mind on whether to formally walk away under UK takeover rules.

It now has to wait six months before launching another bid.

In a statement this afternoon, it said: "Following the AstraZeneca board's rejection of the proposal, Pfizer announces that it does not intend to make an offer for AstraZeneca."

Leif Johansson, chairman of AstraZeneca, said: "We note Pfizer's confirmation that it no longer intends to make an offer for AstraZeneca. We welcome the opportunity to continue building on the momentum we have already demonstrated as an independent company."

He added: "The Board is grateful to Pascal, his management team and to all our employees for their dedication and focus over a period of uncertainty."

The deal’s collapse was instantly welcomed by Labour shadow Business Secretary Chuka Umunna, who was concerned from the outset about the implications for the UK’s science base.

Pfizer had taken pains to promise that 20 per cent of research and development jobs would remain in the UK, but its track record  on previous acquisitions of slashing research budgets and closing research centres still worried the science community.

Memories were still vivid of Pfizer’s closure of its big development site in Kent, where it invented Viagra.

The ghost of Kraft’s takeover of Cadbury also loomed large. That deal saw the American processed cheese giant renege on a promise not to shut a Cadbury factory soon after the takeover had gone through.

AstraZeneca’s board had flatly refused to discuss a deal with the company until it offered more than £55 a share and made clearer proposals on how the deal would avoid disrupting its potentially lucrative programme of inventing new medicines.

At the heart of the controversy was Pfizer’s admission that a key reason for the deal was for it to save tax by moving its domicile, but not its headquarters, to low-tax UK.

Some shareholders were angry that it was this, rather than the long term health of the company, that was driving Pfizer’s management. Given that a large proportion of the purchase price was to be made in shares of the combined company, investors were more concerned about the future than they would have been if it was a simple cash deal.

However, other big Pfizer shareholders including its biggest investor, BlackRock, were irritated that AstraZeneca had not engaged in talks with Pfizer.

Chuka Umunna MP, Labour's Shadow Business Secretary, said: "It is welcome that Pfizer has kept to its promise not to mount a hostile takeover of AstraZeneca, Britain’s second largest pharmaceutical company, following the rejection of its advances by the AstraZeneca Board.

 “We were clear from the start that we would judge the proposed deal on whether it was best for British science, jobs and industry.  We were not confident this was the case which was why we said the Government should subject the deal to a public interest test to determine whether it would have a material adverse impact on the UK’s science and R&D base and, if so, we argued it should be blocked.” 

The Conservatives have been keen to make it clear that this was an issue for the shareholders and company boards to decide upon rather than politicians. But they too were forced into making a show of demanding strong assurances on UK jobs.

Pfizer was also facing a growing backlash in the US, where a political head of steam appears to be building to block US companies from buying foreign companies in order to move their tax domicile to low tax havens like the UK.

At the weekend, it emerged that a US company had made a similar proposal to InterContinental Hotels Group – the British based biggest hotel operator in the world.

It is unlikely that such a deal would lead to calls for a public interest test, however.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: HR Benefits Manager

£40000 - £50000 per annum + pro rata: SThree: SThree Group have been well esta...

Recruitment Genius: Office Manager / Financial Services

£30000 - £37000 per annum: Recruitment Genius: Established in 1999, a highly r...

Jemma Gent: Year End Accountant

£250-£300 Day Rate: Jemma Gent: Are you a qualified accountant with strong exp...

Jemma Gent: Management Accountant

£230 - £260 Day Rate: Jemma Gent: Do you want to stamp your footprint in histo...

Day In a Page

HIV pill: Scientists hail discovery of 'game-changer' that cuts the risk of infection among gay men by 86%

Scientists hail daily pill that protects against HIV infection

Breakthrough in battle against global scourge – but will the NHS pay for it?
How we must adjust our lifestyles to nature: Welcome to the 'Anthropocene', the human epoch

Time to play God

Welcome to the 'Anthropocene', the human epoch where we may need to redefine nature itself
MacGyver returns, but with a difference: Handyman hero of classic 1980s TV series to be recast as a woman

MacGyver returns, but with a difference

Handyman hero of classic 1980s TV series to be recast as a woman
Tunnel renaissance: Why cities are hiding roads down in the ground

Tunnel renaissance

Why cities are hiding roads underground
'Backstreet Boys - Show 'Em What You're Made Of': An affectionate look at five middle-aged men

Boys to men

The Backstreet Boys might be middle-aged, married and have dodgy knees, but a heartfelt documentary reveals they’re not going gently into pop’s good night
Crufts 2015: Should foreign dogs be allowed to compete?

Crufts 2015

Should foreign dogs be allowed to compete?
10 best projectors

How to make your home cinema more cinematic: 10 best projectors

Want to recreate the big-screen experience in your sitting room? IndyBest sizes up gadgets to form your film-watching
Manchester City 1 Barcelona 2 player ratings: Luis Suarez? Lionel Messi? Joe Hart? Who was the star man?

Manchester City vs Barcelona player ratings

Luis Suarez? Lionel Messi? Joe Hart? Who was the star man at the Etihad?
Arsenal vs Monaco: Monaco - the making of Gunners' manager Arsene Wenger

Monaco: the making of Wenger

Jack Pitt-Brooke speaks to former players and learns the Frenchman’s man-management has always been one of his best skills
Cricket World Cup 2015: Chris Gayle - the West Indies' enigma lives up to his reputation

Chris Gayle: The West Indies' enigma

Some said the game's eternal rebel was washed up. As ever, he proved he writes the scripts by producing a blistering World Cup innings
In Ukraine a dark world of hybrid warfare and murky loyalties prevails

In Ukraine a dark world of hybrid warfare

This war in the shadows has been going on since the fall of Mr Yanukovych
'Birdman' and 'Bullets Over Broadway': Homage or plagiarism?

Homage or plagiarism?

'Birdman' shares much DNA with Woody Allen's 'Bullets Over Broadway'
Broadchurch ends as damp squib not even David Tennant can revive

A damp squib not even David Tennant can revive

Broadchurch, Series 2 finale, review
A Koi carp breeding pond, wall-mounted iPads and a bathroom with a 'wellness' shower: inside the mansion of Germany's 'Bishop of Bling'

Inside the mansion of Germany's 'Bishop of Bling'

A Koi carp breeding pond, wall-mounted iPads and a bathroom with a 'wellness' shower